Production (Stage)
Mereo BioPharma Group plc
MREO
$2.74
$0.2811.38%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.89M | -7.05M | -15.00M | -12.26M | -8.95M |
| Total Depreciation and Amortization | 270.00K | 274.00K | 282.00K | 257.00K | 275.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.80M | -3.51M | 8.58M | 2.44M | 2.19M |
| Change in Net Operating Assets | -514.00K | 857.00K | -1.38M | 1.66M | -1.51M |
| Cash from Operations | -8.33M | -9.42M | -7.52M | -7.90M | -7.99M |
| Capital Expenditure | -20.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -300.00K | 0.00 | 0.00 | 1.00K | -700.00K |
| Cash from Investing | -320.00K | 0.00 | 0.00 | 1.00K | -700.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 487.00K | 0.00 | 0.00 | 47.00M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -65.00K | -40.00K | -594.00K | -219.00K | -- |
| Cash from Financing | 422.00K | -40.00K | -594.00K | 46.78M | -- |
| Foreign Exchange rate Adjustments | 908.00K | -1.26M | 1.20M | -107.00K | -70.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.32M | -10.72M | -6.91M | 38.77M | -8.76M |